Abstract
The identification of new mutations in SARS-CoV-2 and their roles in the viral fitness towards evolution and survival to face the selective pressure imposed by the human host immune response have become the target of great attention recently. As result, concerns related to the emergence of novel variants with more transmissibility and pathogenic potential have led many countries to apply more restrictive measures to avoid increase in the number of infections and collapse of healthcare systems. Re-infection of apparently recovered individuals and cases of co-infection with different variants have also been the focus of studies aiming to investigate whether the vaccines currently used may also be protective against the new emerging variants. This commentary is intended to extend the findings underlying the questions related to the impact of new mutations or combination of them to the efficacy of the developed vaccines and possible changes in the clinical features of COVID-19.
Keywords
Genome sequencing, SARS-CoV-2, Vaccine, Immunity, Virus evolution, Mutation